IBDEI0F8 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7326,1,4,0)
 ;;=4^362.29
 ;;^UTILITY(U,$J,358.3,7326,2)
 ;;=^268619
 ;;^UTILITY(U,$J,358.3,7327,0)
 ;;=362.30^^49^556^40
 ;;^UTILITY(U,$J,358.3,7327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7327,1,3,0)
 ;;=3^Hemiretinal Vein Occlusion
 ;;^UTILITY(U,$J,358.3,7327,1,4,0)
 ;;=4^362.30
 ;;^UTILITY(U,$J,358.3,7327,2)
 ;;=^105640
 ;;^UTILITY(U,$J,358.3,7328,0)
 ;;=362.37^^49^556^9
 ;;^UTILITY(U,$J,358.3,7328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7328,1,3,0)
 ;;=3^CRVO-Partial
 ;;^UTILITY(U,$J,358.3,7328,1,4,0)
 ;;=4^362.37
 ;;^UTILITY(U,$J,358.3,7328,2)
 ;;=^268627
 ;;^UTILITY(U,$J,358.3,7329,0)
 ;;=362.50^^49^556^51
 ;;^UTILITY(U,$J,358.3,7329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7329,1,3,0)
 ;;=3^Mac Degen,Senile/Atrophy
 ;;^UTILITY(U,$J,358.3,7329,1,4,0)
 ;;=4^362.50
 ;;^UTILITY(U,$J,358.3,7329,2)
 ;;=^73072
 ;;^UTILITY(U,$J,358.3,7330,0)
 ;;=362.70^^49^556^28
 ;;^UTILITY(U,$J,358.3,7330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7330,1,3,0)
 ;;=3^Degen/Hered Disorder
 ;;^UTILITY(U,$J,358.3,7330,1,4,0)
 ;;=4^362.70
 ;;^UTILITY(U,$J,358.3,7330,2)
 ;;=^268650
 ;;^UTILITY(U,$J,358.3,7331,0)
 ;;=362.74^^49^556^91
 ;;^UTILITY(U,$J,358.3,7331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7331,1,3,0)
 ;;=3^Retinitis Pigmentosa
 ;;^UTILITY(U,$J,358.3,7331,1,4,0)
 ;;=4^362.74
 ;;^UTILITY(U,$J,358.3,7331,2)
 ;;=^105693
 ;;^UTILITY(U,$J,358.3,7332,0)
 ;;=362.75^^49^556^50
 ;;^UTILITY(U,$J,358.3,7332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7332,1,3,0)
 ;;=3^Mac Degen,Juvenile
 ;;^UTILITY(U,$J,358.3,7332,1,4,0)
 ;;=4^362.75
 ;;^UTILITY(U,$J,358.3,7332,2)
 ;;=^268656
 ;;^UTILITY(U,$J,358.3,7333,0)
 ;;=362.76^^49^556^74
 ;;^UTILITY(U,$J,358.3,7333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7333,1,3,0)
 ;;=3^RPE Hypertrophy
 ;;^UTILITY(U,$J,358.3,7333,1,4,0)
 ;;=4^362.76
 ;;^UTILITY(U,$J,358.3,7333,2)
 ;;=^268657
 ;;^UTILITY(U,$J,358.3,7334,0)
 ;;=362.82^^49^556^85
 ;;^UTILITY(U,$J,358.3,7334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7334,1,3,0)
 ;;=3^Retinal Exudates
 ;;^UTILITY(U,$J,358.3,7334,1,4,0)
 ;;=4^362.82
 ;;^UTILITY(U,$J,358.3,7334,2)
 ;;=^268659
 ;;^UTILITY(U,$J,358.3,7335,0)
 ;;=363.12^^49^556^68
 ;;^UTILITY(U,$J,358.3,7335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7335,1,3,0)
 ;;=3^Periph Disem Choroiditis
 ;;^UTILITY(U,$J,358.3,7335,1,4,0)
 ;;=4^363.12
 ;;^UTILITY(U,$J,358.3,7335,2)
 ;;=^268675
 ;;^UTILITY(U,$J,358.3,7336,0)
 ;;=363.15^^49^556^1
 ;;^UTILITY(U,$J,358.3,7336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7336,1,3,0)
 ;;=3^AMPPE
 ;;^UTILITY(U,$J,358.3,7336,1,4,0)
 ;;=4^363.15
 ;;^UTILITY(U,$J,358.3,7336,2)
 ;;=^268678
 ;;^UTILITY(U,$J,358.3,7337,0)
 ;;=363.33^^49^556^96
 ;;^UTILITY(U,$J,358.3,7337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7337,1,3,0)
 ;;=3^Scars of Post Pole of Chorioret
 ;;^UTILITY(U,$J,358.3,7337,1,4,0)
 ;;=4^363.33
 ;;^UTILITY(U,$J,358.3,7337,2)
 ;;=^268681
 ;;^UTILITY(U,$J,358.3,7338,0)
 ;;=363.41^^49^556^97
 ;;^UTILITY(U,$J,358.3,7338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7338,1,3,0)
 ;;=3^Senile Atrophy of Choroid
 ;;^UTILITY(U,$J,358.3,7338,1,4,0)
 ;;=4^363.41
 ;;^UTILITY(U,$J,358.3,7338,2)
 ;;=^268686
 ;;^UTILITY(U,$J,358.3,7339,0)
 ;;=363.43^^49^556^4
 ;;^UTILITY(U,$J,358.3,7339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7339,1,3,0)
 ;;=3^Angioid Streaks
 ;;^UTILITY(U,$J,358.3,7339,1,4,0)
 ;;=4^363.43
 ;;^UTILITY(U,$J,358.3,7339,2)
 ;;=^7492
 ;;^UTILITY(U,$J,358.3,7340,0)
 ;;=363.50^^49^556^42
 ;;^UTILITY(U,$J,358.3,7340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7340,1,3,0)
 ;;=3^Herediatary Chor Dyst/Atrophy
